|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2007-11-12
|
|
pubmed:abstractText |
Mycophenolate mofetil (MMF) is an immunomodulatory drug, and its use in inflammatory bowel disease has previously been reported. The aim of this study was to review the Leeds Colitis Clinic experience of the safety and efficacy of MMF in treating patients with refractory Crohn's disease (CD) and ulcerative colitis (UC). This is an extension of a previously published study from our center with a longer follow-up period and approximately twice the number of patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1078-0998
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1488-92
|
|
pubmed:dateRevised |
2010-3-23
|
|
pubmed:meshHeading |
pubmed-meshheading:17924566-Adult,
pubmed-meshheading:17924566-Aged,
pubmed-meshheading:17924566-Aged, 80 and over,
pubmed-meshheading:17924566-Azathioprine,
pubmed-meshheading:17924566-Colitis, Ulcerative,
pubmed-meshheading:17924566-Crohn Disease,
pubmed-meshheading:17924566-Female,
pubmed-meshheading:17924566-Follow-Up Studies,
pubmed-meshheading:17924566-Humans,
pubmed-meshheading:17924566-Immunosuppressive Agents,
pubmed-meshheading:17924566-Male,
pubmed-meshheading:17924566-Middle Aged,
pubmed-meshheading:17924566-Mycophenolic Acid,
pubmed-meshheading:17924566-Retrospective Studies
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Mycophenolate mofetil therapy for refractory inflammatory bowel disease.
|
|
pubmed:affiliation |
Department of Gastroenterology, Leeds General Infirmary, Lees, United Kingdom.
|
|
pubmed:publicationType |
Journal Article
|
